Medifast (MED) Tops Q4 EPS by 148c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $11.04 -1.87%
EPS Growth %: -295.5%
Financial Fact:
Interest income/ (expense), net: 60K
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -295.5%
Financial Fact:
Interest income/ (expense), net: 60K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $3.70, $1.48 better than the analyst estimate of $2.22. Revenue for the quarter came in at $337.2 million versus the consensus estimate of $330.1 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Goldman starts Talen at buy, sees PJM power tightness boosting earnings
- Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
